Literature DB >> 12905824

[30-year experiences on early detection and treatment of esophageal cancer in high risk areas].

G Q Wang1.   

Abstract

The author had conducted the clinical study on early diagnosis and early therapy of esophageal cancer (EC) in the area of high prevalence for more than 30 years. In the endoscopic survey, 742 patients were diagnosed as early EC from 22,285 participants. The endoscopic appearance of the mucosa in early EC was classified into three types: (1) change of mucosa color: red and white area; (2) Increased thickness and change of the vascular pattern of the mucosa; (3) mucosa morphology: erosion, plaque, coarseness and nodular. Iodine staining under endoscopic examination had promoted the early detection of EC and precancerous lesions. Since 307 patients with EC at early stage (65 carcinoma in situ, 95 intramucosal carcinoma, and 147 submucosal carcinoma) had undergone esophagectomy. There were no lymphatic metastasis in carcinoma in situ, however there were 2 cases (2.11%) of intramucosal carcinoma and 27 cases (18.37%) of submucosal carcinoma with lymph node metastasis. 24-year follow-up, results showed that 5-year survival rate is 84.1% and a 10-year survival rate is 72.9% among the cases of esophagectomy. A 5-year survival rate is 100% in 22 cases followed up for full five years among 141 cases with endoscopic mucosectomy. According to this study, severe dysplasia and some moderate dysplasia were precancerous lesions. Should these precancerous cases be treated, the cancerization risk of target population would reduce dramatically and the incidence of EC would be decreased down to 2/3.

Entities:  

Mesh:

Year:  2001        PMID: 12905824

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  8 in total

1.  Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China.

Authors:  Juan Yang; Wen-Qiang Wei; Jin Niu; Zhi-Cai Liu; Chun-Xia Yang; You-Lin Qiao
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

2.  Endoscopic survey of esophageal cancer in a high-risk area of China.

Authors:  Xu-Jing Lu; Zhi-Feng Chen; Cui-Lan Guo; Shao-Sen Li; Wen-Long Bai; Guo-Liang Jin; Yu-Xia Wang; Fan-Shu Meng; Feng Gao; Jun Hou
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

3.  Molecular analysis in combination with iodine staining may contribute to the risk prediction of esophageal squamous cell carcinoma.

Authors:  Shun He; Guang-Ming Guo; Fu-Xing Liu; Xiao-Ping Huang; Xin Xu; Yan Cai; Ya-Ling Han; Qi-Min Zhan; Min Wu; Jin-Tang Dong; Gui-Qi Wang; Ming-Rong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-14       Impact factor: 4.553

4.  Diagnosis and staging of superficial esophageal precursor based on pre-endoscopic resection system comparable to endoscopic resection.

Authors:  Xiumin Qin; Shun He; Yueming Zhang; Liyan Xue; Ning Lu; Guiqi Wang
Journal:  BMC Cancer       Date:  2014-10-21       Impact factor: 4.430

5.  Cost-benefit analysis of screening for esophageal and gastric cardiac cancer.

Authors:  Wen-Qiang Wei; Chun-Xia Yang; Si-Han Lu; Juan Yang; Bian-Yun Li; Shi-Yong Lian; You-Lin Qiao
Journal:  Chin J Cancer       Date:  2011-03

6.  Accumulated promoter methylation as a potential biomarker for esophageal cancer.

Authors:  Xianzhen Peng; Hengchuan Xue; Lingshuang Lü; Peiyi Shi; Jianping Wang; Jianming Wang
Journal:  Oncotarget       Date:  2017-01-03

7.  Epidemic trend, screening, and early detection and treatment of cancer in Chinese population.

Authors:  Xiao-Nong Zou
Journal:  Cancer Biol Med       Date:  2017-02       Impact factor: 4.248

8.  Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer.

Authors:  Huan-Qiang Wang; Cong-Ying Yang; Si-Yuan Wang; Tian Wang; Jing-Ling Han; Kai Wei; Fu-Cun Liu; Ji-da Xu; Xian-Zhen Peng; Jian-Ming Wang
Journal:  J Biomed Res       Date:  2018-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.